The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
Top Cited Papers
- 18 June 2021
- journal article
- review article
- Published by Elsevier BV in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (10), 3546-3567
- https://doi.org/10.1016/j.jaip.2021.06.006
Abstract
No abstract availableKeywords
Funding Information
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
This publication has 107 references indexed in Scilit:
- Hypersensitivity to Polyethylene GlycolsThe Journal of Clinical Pharmacology, 2013
- Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgEJournal of Allergy and Clinical Immunology, 2012
- Biologic-induced urticaria due to polysorbate 80: usefulness of prick testBritish Journal of Dermatology, 2011
- AGREE II: advancing guideline development, reporting and evaluation in health careCMAJ : Canadian Medical Association Journal, 2010
- Diagnostic Utility of Two Case Definitions for AnaphylaxisDrug Safety, 2010
- Grading quality of evidence and strength of recommendations in clinical practice guidelinesAllergy, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Usefulness of oral macrogol challenge in anaphylaxis after intra-articular injection of corticosteroid preparationAllergy, 2008
- Two cases of anaphylaxis to macrogol 6000 after ingestion of drug tabletsAllergy, 2006
- Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactionsAnnals of Allergy, Asthma & Immunology, 2005